Eradicating polio: Today's challenges and tomorrow's legacy

Annals of Tropical Medicine and Parasitology

Volumn 100, Issue 5-6, 2006, Pages 401-413

  Aylward, R B ^a  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

INACTIVATED POLIOVIRUS VACCINE; INACTIVATED VACCINE; JAPANESE ENCEPHALITIS VACCINE; MEASLES VACCINE; ORAL POLIOMYELITIS VACCINE; RUBELLA VACCINE; TETANUS TOXOID; UNCLASSIFIED DRUG; YELLOW FEVER VACCINE;

DEVELOPING COUNTRY; EPIDEMIC ENCEPHALITIS; ERADICATION THERAPY; FLACCID PARALYSIS; HEALTH CARE ORGANIZATION; HEALTH PROGRAM; HEALTH SERVICE; HEALTH SURVEY; HUMAN; IMMUNIZATION; INFECTION RISK; MEASLES; POLIOMYELITIS; POLIOMYELITIS VIRUS; REVIEW; RUBELLA; TETANUS; VIRUS TRANSMISSION; YELLOW FEVER; DISEASE TRANSMISSION; EPIDEMIC; HEALTH; INTERNATIONAL COOPERATION; MASS IMMUNIZATION;

JAPANESE ENCEPHALITIS VIRUS; POLIOVIRUS; RUBELLA;

DISEASE OUTBREAKS; HUMANS; INTERNATIONAL COOPERATION; MASS IMMUNIZATION; POLIOMYELITIS; WORLD HEALTH;

EID: 34250767182     PISSN: 00034983     EISSN: None     Source Type: Journal    
DOI: 10.1179/136485906X97354     Document Type: Review

References (39)

1. Andrus, J. K., Thapa, A. B., Withana, N., Fitzsimmons, J. W., Abeykoon, P. & Aylward, B. (2001). A new paradigm for international disease control: lessons learned from polio eradication in Southeast Asia. American Journal of Public Health, 91, 146-150.
2. Andrus, J. K., Ashley, D., Dowdle, W. R., Feinglass, E. S., John, T. J., Kitua, A. Y., Marandi, A. & Reich, M. R. (2002). Polio immunization policy in the post-certification era. Criteria for policy development. In Institute for Global Health & Taskforce for Child Survival and Development. Global Health Forum III. Post-certification Polio Immunization Policy, pp. 6-14. San Francisco, CA: Institute for Global Health.
3. Anon. (1996). Resolution AHG/Decl.1 (XXXII): Yaounde Declaration on Polio Eradication in Africa. Yaounde, Cameroon: Organization of African Unity.
4. Anon. (2001). 'Endgame' issues for the global polio eradication initiative. Clinical Infectious Diseases, 34, 72-77.
5. Anon. (2004). Acute flaccid paralysis surveillance for expansion to other diseases, 2003-2004. Morbidity and Mortality Weekly Report, 53, 1113-1116.
6. Aylward, R. B. & Linkins, J. (2005). Polio eradication: mobilizing and managing the human resources. Bulletin of the World Health Organization, 83, 268-273.
7. Aylward, R. B., Acharya, A., England, S., Agocs, M. & Linkins, J. (2003). Global health goals: lessons from the worldwide effort to eradicate poliomyelitis. Lancet, 362, 909-914.
8. Aylward, R. B., Sutter, R. & Heymann, D. L. (2005). OPV cessation - the final step to a 'polio-free' world. Science, 310, 625-626.
9. Bart, K. J., Foulds, J. & Patriarca, P. (1996). Global eradication of poliomyelitis: benefit-cost analysis. Bulletin of the World Health Organization, 74, 35-45.
10. Cruz, P. R. (1984). Cuba: mass polio vaccination program, 1962-1982. Reviews of Infectious Diseases, 6 (Suppl.), S408-S412.
11. De Quadros, C. A., Hersh, B. S., Olivé, J. M., Andrus, J. K., da Silveira, C. M. & Carrasco, P. A. (1991). Eradication of poliomyelitis: progress in the Americas. Pediatric Infectious Disease Journal, 10, 222-229.
12. De Quadros, C. A., Andrus, J. K., Olivé, J. M. & Guerra de Macedo, C. (1992). Polio eradication from the western hemisphere. Annual Review of Public Health, 13, 239-252.
13. Dowdle, W. R. & Cochi, S. L. (2002). Global eradication of poliovirus: history and rationale. In Molecular Biology of Picornaviruses, eds Semler, B. L. & Wimmer, E. pp. 473-480. Washington, DC: ASM Press.
14. Duintjer Tebbens, R. J., Pallansch, M. A., Kew, O. M., Cáceres, V. M., Jafari, H., Cochi, S. L., Sutter, R. W., Aylward, R. B. & Thompson, K. M. (2006). Risks of paralytic disease due to wild or vaccine-derived poliovirus after eradication. Risk Analysis, in press.
15. Henderson, D. A. (2001). Countering the post eradication threat of smallpox and polio. Clinical Infectious Diseases, 33, 79-83.
16. Heymann, D. L. & Aylward, R. B. (2004). Global health: eradicating polio. New England Journal of Medicine, 351, 1275-1277.
17. Hull, H. F., Ward, N. A., Hull, B. P., Milstien, J. B. & de Quadros, C. A. (1994). Paralytic poliomyelitis: seasoned strategies, disappearing disease. Lancet, 343, 1331-1337.
18. Kew, O., Morris-Glasgow, V., Landaverde, M., Burns, C., Shaw, J., Garib, Z., Andre, J., Blackman, E., Freeman, C. J., Jorba, J., Sutter, R., Tambini, G., Venczel, L., Pedreira, C., Laender, F., Shimizu, H., Yoneyama, T., Miyamura, T., van der Avoort. H., Oberste, M. S., Kilpatrick, D., Cochi, S., Pallansch, M. & de Quadros, C. (2002). Outbreak of poliomyelitis in Hispaniola associated with circulating type 1 vaccine-derived poliovirus. Science, 296, 356-359.
19. Kew, O. M., Wright, P. F., Agol, V. I., Delpeyroux, F., Shimizou, H., Nathanson, N. & Pallansch, M. (2004). Circulating vaccine-derived polioviruses: current state of knowledge. Bulletin of the World Health Organization, 82, 16-23.
20. MacLennan, C., Dunn, G., Huissoon, A. P., Kumararatne, D. S., Martin, J., O'Leary, P., Thompson, R. A., Osman, H., Wood, P., Minor, P., Wood, D. J. & Pillay, D. (2004). Failure to clear persistent vaccine-derived neurovirulent poliovirus infection in an immunodeficient man. Lancet, 363, 1509-1513.
21. Pan American Health Organization (1985). Director announces campaign to eradicate poliomyelitis from the Americas by 1990. Bulletin of the Pan American Health Organization, 19, 213-215.
22. Risi, J. B. (1984). The control of poliomyelitis in Brazil. Reviews of Infectious Diseases, 6 (Suppl. 2), S391-S396.
23. Rotz, L. D., Khan, A. S., Lillibridge, S. R., Ostroff, S. M. & Hughes, J. M. (2002). Public health assessment of potential biological terrorism agents. Emerging Infectious Diseases, 8, 225-230.
24. Rousset, D., Rakoto-Andrianarivelo, M., Razafindratsimandresy, R., Randriamanalina, B., Guillot, S., Balanant, J., Mauclere, P. & Delpeyroux, F. (2003). Recombinant vaccine-derived poliovirus in Madagascar. Emerging Infectious Diseases, 9, 885-887.
25. Shimizu, H., Thorley, B., Paladin, F. J., Brussen, K. A., Stambos, V., Yuen, L., Utama, A., Tano, Y., Arita, M., Yoshida, H., Yoneyama, T., Benegas, A., Roesel, S., Pallansch, M., Kew, O. & Miyamura, T. (2004). Circulation of type 1 vaccine-derived poliovirus in the Philippines in 2001. Journal of Virology, 78, 13,512-13,521.
26. World Health Organization (1988). World Health Assembly Resolution WHA41.28: Global Eradication of Poliomyelitis by the Year 2000. Geneva: WHO.
27. World Health Organization (1996). Update: mass vaccination with oral poliovirus vaccine - Asia and Europe, 1996. Weekly Epidemiological Record, 71, 329-332.
28. World Health Organization (1997). Final stages of polio eradication, WHO Western Pacific Region, 1997-1998. Weekly Epidemiological Record, 74, 20-24.
29. World Health Organization (1999). World Health Assembly Resolution 52.22: Poliomyelitis Eradication. Geneva: WHO.
30. World Health Organization (2000). Progress towards poliomyelitis eradication, WHO European Region, June 1998-June 2000. Weekly Epidemiological Record, 75, 241-246.
31. World Health Organization (2001). Transmission of wild poliovirus type 2 - apparent global interruption. Weekly Epidemiological Record, 76, 95-97.
32. World Health Organization (2002). Progress towards the global eradication of poliomyelitis, 2001. Weekly Epidemiological Record, 77, 97-108.
33. World Health Organization (2003). Report of the Interim Meeting of the Technical Consultative Group (TCG) on the Global Eradication of Poliomyelitis, Geneva, 13-14 November 2002. Document WHO/V&B/03.04. Geneva: World Health Organization.
34. World Health Organization (2004a). Global polio eradication strategic plan 2004-2008. Weekly Epidemiological Record, 79, 55-57.
35. World Health Organization (2004b). Progress towards global eradication of poliomyelitis, 2003 and January-April 2004. Weekly Epidemiological Record, 79, 229-234.
36. World Health Organization (2004c). Conclusions and Recommendations of the Ad Hoc Advisory Committee on Poliomyelitis Eradication, Geneva, 21-22 September 2004. Weekly Epidemiological Record, 79, 401-408.
37. World Health Organization (2004d). Report of an Informal Consultation on the Identification and Management of Vaccine-derived Polioviruses (VDPVs). Geneva: WHO.
38. World Health Organization (2005). Conclusions and Recommendations of the Advisory Committee on Poliomyelitis Eradication, Geneva, 11-12 October 2005. Weekly Epidemiological Record, 80, 410-416.
39. World Health Organization (2006). Global Polio Eradication Initiative. Financial Resource Requirements 2006-2008. Geneva: WHO.